img
Protection of farm goats by combinations of recombinant peptides and formalin inactivated spores from a lethal Bacillus anthracis challenge under field conditions..    
Yazarlar
Susanne Koehler
Türkiye
Prof. Dr. Fatih BÜYÜK Prof. Dr. Fatih BÜYÜK
Kafkas Üniversitesi, Türkiye
Prof. Dr. Özgür ÇELEBİ Prof. Dr. Özgür ÇELEBİ
Kafkas Üniversitesi, Türkiye
Hayati Demiraslan
Türkiye
Mehmet Doğanay
Erciyes Üniversitesi, Türkiye
Prof. Dr. Mitat ŞAHİN Prof. Dr. Mitat ŞAHİN
Kafkas Üniversitesi, Türkiye
Jens Moehring
Türkiye
Ndumnego Okechukwu
Türkiye
Prof. Dr. Salih OTLU Prof. Dr. Salih OTLU
Kafkas Üniversitesi, Türkiye
Van Heerden Henriette
Türkiye
W Beyer
Türkiye
Özet
Background: Bacillus (B.) anthracis, the causal agent of anthrax, is effectively controlled by the Sterne live spore vaccine (34F2) in animals. However, live spore vaccines are not suitable for simultaneous vaccination and antibiotic treatment of animals being at risk of infection in an outbreak situation. Non-living vaccines could close this gap. Results: In this study a combination of recombinant protective antigen and recombinant Bacillus collagen-like antigen (rBclA) with or without formalin inactivated spores (FIS), targeted at raising an immune response against both the toxins and the spore of B. anthracis, was tested for immunogenicity and protectiveness in goats. Two groups of goats received from local farmers of the Kars region of Turkey were immunized thrice in three weeks intervals and challenged together with non-vaccinated controls with virulent B. anthracis, four weeks after last immunization. In spite of low or none measurable toxin neutralizing antibodies and a surprisingly low immune response to the rBclA, 80% of the goats receiving the complete vaccine were protected against a lethal challenge. Moreover, the course of antibody responses indicates that a two-step vaccination schedule could be sufficient for protection. Conclusion: The combination of recombinant protein antigens and FIS induces a protective immune response in goats. The non-living nature of this vaccine would allow for a concomitant antibiotic treatment and vaccination procedure. Further studies should clarify how this vaccine candidate performs in a post infection scenario controlled by antibiotics.
Anahtar Kelimeler
Animal vaccine | Anthrax | Bacillus anthracis | Vaccination
Makale Türü Özgün Makale
Makale Alt Türü SSCI, AHCI, SCI, SCI-Exp dergilerinde yayımlanan tam makale
Dergi Adı BMC Veterinary Research
Dergi ISSN 1746-6148
Dergi Tarandığı Indeksler SCI-Expanded
Makale Dili İngilizce
Basım Tarihi 01-2017
Cilt No 13
Sayı 1
Doi Numarası 10.1186/s12917-017-1140-2